Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Popliteal Block for Fibula Free Flap Donor Site Pain
NCT03607227Phase 4Completed
- Sponsor
- Region Skåne
- Start
- Sep 2018
- Primary completion
- Apr 2021
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of levobupivacaine, ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Region Skåne. Started Sep 2018; status: completed.
02
Drugs
levobupivacaineropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03607227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03607227.